MetaCap

Candel Therapeutics Insider Trades

NASDAQ: CADLHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

9.94+0.28 (+2.90%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
1 · $3.00M
Sales
5 · $3.55M
Shares bought / sold
550.46K / 317.69K
Net activity
Net selling $550,707

Candel Therapeutics insider activity

Over the last 12 months, Candel Therapeutics insiders reported 7 transactions on SEC Form 4: 1 open-market purchase and 5 sales. Insiders bought $3.0 million and sold $3.6 million worth of stock, for net insider selling of $550,707. The largest seller was Tak Paul Peter, with $3.2 million in reported sales.

The most recent filing shows Tak Paul Peter (Chief Executive Officer) selling 59,379 shares at $10.46 on Sep 11, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CADL's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

CADL insider transactions

Candel Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Sep 11, 2026Tak Paul PeterChief Executive OfficerSale59,379$620.89KForm 4
Sep 10, 2026Tak Paul PeterChief Executive OfficerSale220,866$2.54MForm 4
Sep 10, 2026Tak Paul PeterChief Executive OfficerOption exercise125,000$193.75KForm 4
Aug 17, 2026Tyagarajan SeshuChief Technology OfficerSale7,000$84.00KForm 4
Jun 29, 2026Tyagarajan SeshuChief Technology OfficerSale7,000$70.15KForm 4
Jun 29, 2026Barone FrancescaChief Scientific OfficerSale23,447$235.77KForm 4
Feb 23, 2026Manning Paul BDirectorBuy550,458$3.00MForm 4
Jul 28, 2025Nichols William GarrettChief Medical OfficerSale937$6.54KForm 4
Jul 28, 2025Nichols William GarrettChief Medical OfficerOption exercise937$1.21KForm 4
Jun 30, 2025Nichols William GarrettChief Medical OfficerSale781$3.94KForm 4
Jun 30, 2025Nichols William GarrettChief Medical OfficerOption exercise781$1.01KForm 4
Jun 25, 2025Barone FrancescaChief Scientific OfficerAward4,282$20.00KForm 4
Jun 25, 2025Schoch CharlesChief Financial OfficerAward5,353$25.00KForm 4
Jun 25, 2025Nabel Gary J.DirectorAward5,353$25.00KForm 4
Jun 25, 2025Loggia NicolettaDirectorAward2,141$10.00KForm 4
Jun 25, 2025Martell ChristopherDirectorAward111,349$520.00KForm 4
Jun 25, 2025Manning Paul BDirectorAward1,070,663$5.00MForm 4
Jun 25, 2025Tak Paul PeterChief Executive OfficerAward42,826$200.00KForm 4
Jun 25, 2025Tyagarajan SeshuChief Technology OfficerAward5,353$25.00KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related